News
Bengaluru-headquartered Strides Pharma Science Ltd on Monday said it would spin off its contract development and manufacturing organisation (CDMO) and soft gelatin business into a new entity ...
Shares of Strides Pharma Science Ltd are in focus on Wednesday morning after the drugmaker said its associate company, OneSource Specialty Pharma, has received confirmed commitments for ...
BENGALURU, Sept 25 (Reuters) - India's Strides Pharma Science (SRID.NS), opens new tab on Monday said it would spin off its contract development and manufacturing organisation (CDMO) and soft ...
Pharmaceutical company Strides Pharma has received board approval for a scheme of arrangement to create a separate contract development and manufacturing entity called OneSource. The new entity ...
Suven Pharmaceuticals said that it will be disclosing the information on the shareholding details on May 8. Strides Pharma is set to demerge from Arco Labs, a global capability centre, the company ...
Hosted on MSN1y
Strides Pharma Reports Net Profit Of ₹10.44 Cr In Q4FY24Strides Pharma Science Ltd on Wednesday reported a consolidated net profit of Rs 10.44 crore in the fourth quarter ended March 2024. Financial Highlights The company, which posted a consolidated ...
Strides Pharma share price falls over 3% on plans to spin off CDMO, gelatin biz into separate entity
Strides Pharma share price was down 5.5% from its 52-week high of ₹549.00 apiece hit on September 25.(Photo: Company Website) Strides Pharma Science share price declined over 3% in early trade ...
Strides has introduced OneSource, a standalone specialised pharmaceutical CDMO (Contract Development and Manufacturing Organization). The company’s announcement revealed that OneSource emerged ...
Strides Pharma Science Limited, a global pharmaceutical company headquartered in Bengaluru, announced on October 27 that its subsidiary, Strides Pharma Global Pte Ltd in Singapore, has entered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results